Standard BioTools Past Performance
How has Standard BioTools performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LAB is currently unprofitable.
Growing Profit Margin: LAB is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: LAB is unprofitable, and losses have increased over the past 5 years at a rate of 17.5% per year.
Accelerating Growth: Unable to compare LAB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LAB is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (16.2%).
Return on Equity
High ROE: LAB has a negative Return on Equity (-71.9%), as it is currently unprofitable.